z-logo
Premium
Local immune reaction in syngeneic mice against tumorigenic and nontumorigenic BPV‐transformed mouse cell lines
Author(s) -
Laatikainen AINO,
Sarkkinen HANNU,
SyrjÄNen KARI,
MantyjÄRvi RAUNO
Publication year - 1990
Publication title -
apmis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 88
eISSN - 1600-0463
pISSN - 0903-4641
DOI - 10.1111/j.1699-0463.1990.tb05014.x
Subject(s) - cytotoxicity , cytotoxic t cell , immunogenicity , cell culture , immune system , transplantation , antigen , biology , immunology , cell , cancer research , in vitro , medicine , genetics
The role of cytotoxic T cells in immune response to Bovine Papillomavirus type 1 (BPVl)‐transformed mouse cell lines was assessed. The chromium release assay was used to follow the induction of cytotoxicity in local lymph nodes of syngeneic C57BL/6J (B6) mice after injection of BPV1‐transformed cell lines tumorigenic in nude mice but tumorigenic or nontumorigenic in B6 mice. The nontumorigenic cell line B6B31. C‐NuT.A induced cell line‐specific cytotoxicity with a maximal activity on day 7 after subcutaneous inoculation of one million B6B31.C‐NuT.A cells. After injection of nontumorigenic B6B31.J or tumorigenic B6B31 J‐NuT. A or B6B31. A cell lines, only low levels of nonspecific cytotoxicity were observed. These results suggest a role for cytotoxic T cells only in rejection of B6B31. C‐NuT. A cells. One reason for the poor immunogenicity could be the lack of transformation‐induced/virus‐specific antigens on most of the present BPV1‐transformed cell lines. However, in a transplantation rejection experiment, protection was induced in B6 mice against a challenge of the highly tumorigenic B6B31.A‐B6T. 1 line by repeated injections of BPV1 ‐transformed cells. These results suggest the expression of common transplantation rejection antigens on the three BPV 1‐transformed cell lines used in the immunization experiments.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here